UK Companies House feature
BIOMEDICAL DATA SOLUTIONS LIMITED
Profile
- Company number
- 02291703
- Status
- Active
- Incorporation
- 1988-08-31
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62012
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As at the balance sheet date, the company has net assets of £4,160,723 and cash of £1,385,380. The Directors have prepared a going concern assessment based upon post year end and forecast trading for the company. The directors have performed sensitivity analysis on these forecasts and concluded the company is able to meet its obligations as they fall due, for at least 12 months from signing these financial statements. The company has done modelling of revenues by project, including levels of new customer acquisition, recurring subscription revenue and churn rates. Detailed modelling has been performed on the level of costs and investments required, taking account of inflation and other macroeconomic trends. The conversion of trading into cash was also modelled, taking account of project timings, liability repayments and potential taxation liabilities. On this basis, the directors are satisfied it is appropriate to prepare these financial statements on a going concern basis.”
Subsidiaries
- Sanguin International Inc. · 100% held · United States of America · Software systems supplier
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSON, Ryan | Director | 2025-02-11 | May 1995 | British |
| STEAD, Rebecca | Director | 2019-04-01 | Oct 1979 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEXTER, Mark | Secretary | 2012-02-13 | 2015-10-13 |
| DUCKWORTH, Anthony John | Secretary | — | 1999-08-31 |
| GREENWOOD-PHILLIPS, Benjamin | Secretary | 2025-02-11 | 2026-03-04 |
| WHELAN, Richard | Secretary | 1999-08-31 | 2012-02-13 |
| BAKKER, Pascal Denijs | Director | 2024-09-09 | 2025-02-11 |
| DEXTER, Mark | Director | 2011-11-01 | 2015-10-13 |
| DUCKWORTH, Anthony John | Director | — | 2001-02-01 |
| HIGGS, Connie | Director | 2015-11-01 | 2020-04-30 |
| HILL, Ian | Director | 2015-11-01 | 2018-10-31 |
| KUENZEL, Andreas | Director | 2014-07-01 | 2020-04-30 |
| PIEK, Jurriaan Leonard Jan Frederik | Director | 2020-05-04 | 2024-09-09 |
| PITTS, Elaine | Director | 1995-09-01 | 2014-07-31 |
| ROBERTS, Philip Richard | Director | 2011-03-15 | 2011-10-31 |
| SIEGLE, Robert, Dr | Director | 2011-03-15 | 2014-07-04 |
| VALE, David Roger | Director | — | 2007-10-31 |
| WHELAN, Richard | Director | — | 2012-05-25 |
| WOLFINGER, Markus Karl | Director | 2006-03-10 | 2011-03-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stratec Biomedical Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence | 2016-04-06 | Ceased 2020-05-04 |
Filing timeline
Last 20 of 143 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-12 | TM02 | officers | termination secretary company with name termination date |
| 2025-09-19 | AA | accounts | accounts with accounts type full |
| 2025-09-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-02-12 | AP03 | officers | appoint person secretary company with name date |
| 2025-02-12 | TM01 | officers | termination director company with name termination date |
| 2025-02-12 | AP01 | officers | appoint person director company with name date |
| 2024-10-08 | AA | accounts | accounts with accounts type full |
| 2024-09-22 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-09-22 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-09-22 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-09-18 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-09-09 | AP01 | officers | appoint person director company with name date |
| 2024-09-09 | TM01 | officers | termination director company with name termination date |
| 2024-04-03 | AA | accounts | accounts with accounts type full |
| 2023-11-08 | AD01 | address | change registered office address company with date old address new address |
| 2023-10-30 | AD01 | address | change registered office address company with date old address new address |
| 2023-09-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-05 | AA | accounts | accounts with accounts type full |
| 2022-09-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-15 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory